Litcius/Paper detail

mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics

Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, Shruti Soni, Avinash Khadela, Jinal Ajabiya

2022Vaccines79 citationsDOIOpen Access PDF

Abstract

An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been sparked by the COVID-19 pandemic. Two years ago, COVID-19's launch propelled mRNA-based technologies into the public eye. Knowledge gained from mRNA technology used to combat COVID-19 is assisting in the creation of treatments and vaccines to treat existing illnesses and may avert pandemics in the future. Exploiting the capacity of mRNA to create therapeutic proteins to impede or treat a variety of illnesses, including cancer, is the main goal of the quickly developing, highly multidisciplinary field of biomedicine. In this review, we explore the potential of mRNA as a vaccine and therapeutic using current research findings.

Topics & Concepts

PandemicBiomedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVariety (cybernetics)MedicineMultidisciplinary approachIntensive care medicineVirologyPolitical scienceDiseaseBioinformaticsBiologyInfectious disease (medical specialty)Computer sciencePathologyArtificial intelligenceLawOutbreakSARS-CoV-2 and COVID-19 ResearchRNA Interference and Gene DeliveryViral gastroenteritis research and epidemiology
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics | Litcius